Price movement over the last 24 hours
Alcon AG vs Occidental Petroleum Corporation — how do they compare? Alcon AG trades at $66.84 (market cap $32.69B), while Occidental Petroleum Corporation trades at $53.66 (market cap $51.40B). The key difference: Occidental Petroleum Corporation is the larger of the two by market cap, and Occidental Petroleum Corporation pays the higher dividend (2.01%). Which is the better fit depends on your goals.
| ALC | OXY | |
|---|---|---|
Market Cap | $32.69B | $51.40B |
Sector | Health | Energy |
52-Week High | $92.22 | $66.24 |
52-Week Low | $62.02 | $38.92 |
Enterprise Value | $36.28B | $72.49B |
Dividend Yield | 0.54% | 2.01% |
Signals from Pluang's Aura AI — not financial advice
ALC trades at $66.87, down 4.01% on the day, amid a mixed technical and fundamental backdrop. The stock exhibits a bullish technical signal overall, with moving averages supporting a positive trend, while oscillators remain neutral. Fundamentally, revenue growth is steady, reaching $10.40 billion in 2025, though net income margin compressed to 7.7%. Recent news highlights product innovation, including a collaboration with RxSight for adjustable PCIOLs, signaling ongoing R&D investment. Analyst sentiment is predominantly positive, with a consensus price target of $86.00 implying significant upside.
The outlook for ALC is cautiously optimistic, driven by new product launches and strategic partnerships that may fuel growth. However, risks include competitive pressures, macroeconomic headwinds, and margin compression. With a P/E of 40.92, the valuation appears rich relative to historical norms, requiring strong earnings delivery to justify current levels. Investors should weigh robust analyst buy ratings against execution risks and market volatility.
Occidental Petroleum (OXY) trades at $51.68, up 5.66% with strong recent earnings beats. The stock shows bearish technical signals but attractive valuation with EV/EBITDA of 6.34x. Recent CEO transition and debt reduction efforts are key developments, while oil price volatility remains a primary factor. Analyst consensus leans positive with 48% buy ratings and $66.86 price target suggesting 29% upside potential from current levels.
OXY presents value opportunity with reasonable valuation and consistent earnings outperformance, though exposure to oil prices and execution risks under new leadership warrant caution. The company's pivot toward carbon capture technologies and Permian Basin strength provide long-term growth catalysts, but near-term performance depends on commodity price stability and successful debt management.
Trailing returns across standard periods
Latest headlines on both assets
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →Occidental Petroleum is an independent exploration and production company with operations in the United States, Latin America, and the Middle East. At the end of 2021, the company reported net proved reserves of 3.5 billion barrels of oil equivalent. Net production averaged 1,174 thousand barrels of oil equivalent per day in 2021 at a ratio of 75% oil and natural gas liquids and 25% natural gas.
Read more on OXY →